Introduction Tuberculosis (TB) is the most common serious opportunistic infection among people with Human Immunodeficiency Virus (HIV) infection and are considered as the …
A Gemechu, A Mihret, FA Atire, A Aseffa… - Tropical Medicine and …, 2023 - mdpi.com
There have been limited studies linking baseline factors, including the viral load (VL) test, with virological non-suppression since the introduction of dolutegravir (DTG)-based …
Abstract Background In sub-Saharan Africa, data on virologic outcomes of young people living with HIV (YLWH) enrolled on antiretroviral therapy (ART) remains scarce. In this study …
United Nations program on HIV/AIDS 90–90-90 ambitious goal recommends 90% of people living with HIV and taking antiretroviral therapy should achieve viral suppression by 2020 …
EW Hedima, JD Ohieku, EA David, NY Ikunaiye… - Exploratory Research in …, 2024 - Elsevier
Background People living with HIV/AIDS (PLHIV) are prone to other health issues that may result from the disease or antiretroviral medicines. These persons experience other …
Background Treatment with effective antiretroviral therapy (ART) reduces viral load as well as HIV-related morbidity and mortality in HIV-positive patients. Despite the expanded …
T Kiros, A Taye, L Workineh, T Eyayu, S Damtie… - Heliyon, 2022 - cell.com
Background Highly active antiretroviral therapy (HAART) improves clinical outcomes by suppressing viral replication and allowing immune reconstitution. It also reduces HIV-related …
A Abie, M Damessa - HIV/AIDS-Research and Palliative Care, 2023 - Taylor & Francis
Introduction Despite the high prevalence of age-associated comorbidities in HIV patients in sub-Saharan Africa, there is a lack of data on their influence on treatment outcomes in HIV …
Objective This study aimed to pool the prevalence of virological failure and associated factors. Design Systematic review and meta-analysis. Primary outcome measure Prevalence …